In new independent research reports released early this morning,
Capital Review released its latest key findings for all current
investors, traders, and shareholders of Pareteum Corp.
(NASDAQ:TEUM), Discovery Communications, Inc. (NASDAQ:DISCK),
Midstates Petroleum Co. (NYSE:MPO), Watsco, Inc. (NYSE:WSO),
Collegium Pharmaceutical, Inc. (NASDAQ:COLL), and Cross Country
Healthcare, Inc. (NASDAQ:CCRN), including updated fundamental
summaries, consolidated fiscal reporting, and fully-qualified
certified analyst research.
Complimentary Access: Research Reports
Full copies of recently published reports are available
to readers at the links below.
TEUM DOWNLOAD:
http://Capital-Review.com/register/?so=TEUM DISCK DOWNLOAD:
http://Capital-Review.com/register/?so=DISCK MPO DOWNLOAD:
http://Capital-Review.com/register/?so=MPO WSO DOWNLOAD:
http://Capital-Review.com/register/?so=WSO COLL DOWNLOAD:
http://Capital-Review.com/register/?so=COLL CCRN DOWNLOAD:
http://Capital-Review.com/register/?so=CCRN
(You may have to copy and paste the link into your browser and
hit the [ENTER] key)
The new research reports from Capital Review,
available for free download at the links above, examine Pareteum
Corp. (NASDAQ:TEUM), Discovery Communications, Inc. (NASDAQ:DISCK),
Midstates Petroleum Co. (NYSE:MPO), Watsco, Inc. (NYSE:WSO),
Collegium Pharmaceutical, Inc. (NASDAQ:COLL), and Cross Country
Healthcare, Inc. (NASDAQ:CCRN) on a fundamental level and outlines
the overall demand for their products and services in addition to
an in-depth review of the business strategy, management discussion,
and overall direction going forward. Several excerpts from the
recently released reports are available to today's readers
below.
-----------------------------------------
Important Notice: the following
excerpts are not designed to be standalone summaries and as such,
important information may be missing from these samples. Please
download the entire research report, free of charge, to ensure you
are reading all relevant material information. Percentage
calculations are performed after rounding. All amounts in millions
(MM), except per share amounts.
-----------------------------------------
PARETEUM CORP. (TEUM) REPORT OVERVIEW
Pareteum's Recent Financial Performance
For the three months ended December 31st, 2018
vs December 31st, 2017, Pareteum reported revenue of $14.31MM vs
$4.01MM (up 256.50%) and analysts estimated basic earnings per
share -$0.07 vs -$0.36. For the twelve months ended December 31st,
2018 vs December 31st, 2017, Pareteum reported revenue of $32.44MM
vs $13.55MM (up 139.42%) and analysts estimated basic earnings per
share -$0.20 vs -$0.76. Analysts expect earnings to be released on
May 6th, 2019. The report will be for the fiscal period ending
March 31st, 2019. The reported EPS for the same quarter last year
was -$0.04. The estimated EPS forecast for the next fiscal year is
$0.18 and is expected to report on March 10th, 2020.
To read the full Pareteum Corp. (TEUM) report, download it here:
http://Capital-Review.com/register/?so=TEUM
-----------------------------------------
DISCOVERY COMMUNICATIONS, INC. (DISCK) REPORT
OVERVIEW
Discovery Communications' Recent Financial
Performance
For the three months ended December 31st, 2018
vs December 31st, 2017, Discovery Communications reported revenue
of $2,809.00MM vs $1,864.00MM (up 50.70%) and analysts estimated
basic earnings per share $0.41 vs -$1.99. For the twelve months
ended December 31st, 2018 vs December 31st, 2017, Discovery
Communications reported revenue of $10,553.00MM vs $6,873.00MM (up
53.54%) and analysts estimated basic earnings per share $0.86 vs
-$0.59. Analysts expect earnings to be released on May 2nd, 2019.
The report will be for the fiscal period ending March 31st, 2019.
Reported EPS for the same quarter last year was $0.53. The
estimated EPS forecast for the next fiscal year is $3.83 and is
expected to report on February 25th, 2020.
To read the full Discovery Communications, Inc. (DISCK) report,
download it here:
http://Capital-Review.com/register/?so=DISCK
-----------------------------------------
MIDSTATES PETROLEUM CO. (MPO) REPORT
OVERVIEW
Midstates Petroleum's Recent Financial
Performance
For the three months ended December 31st, 2018
vs December 31st, 2017, Midstates Petroleum reported revenue of
$69.64MM vs $53.34MM (up 30.55%) and analysts estimated basic
earnings per share $1.38 vs -$4.78. For the twelve months ended
December 31st, 2018 vs December 31st, 2017, Midstates Petroleum
reported revenue of $208.64MM vs $228.75MM (down 8.79%) and
analysts estimated basic earnings per share $1.91 vs -$3.39.
Analysts expect earnings to be released on May 8th, 2019. The
report will be for the fiscal period ending March 31st, 2019.
To read the full Midstates Petroleum Co. (MPO) report, download
it here:
http://Capital-Review.com/register/?so=MPO
-----------------------------------------
WATSCO, INC. (WSO) REPORT OVERVIEW
Watsco's Recent Financial Performance
For the three months ended December 31st, 2018
vs December 31st, 2017, Watsco reported revenue of $991.33MM vs
$964.35MM (up 2.80%) and basic earnings per share $1.08 vs $1.21
(down 10.74%). For the twelve months ended December 31st, 2018 vs
December 31st, 2017, Watsco reported revenue of $4,546.65MM vs
$4,341.96MM (up 4.71%) and analysts estimated basic earnings per
share $6.50 vs $5.81 (up 11.88%). Analysts expect earnings to be
released on April 23rd, 2019. The report will be for the fiscal
period ending March 31st, 2019. The reported EPS for the same
quarter last year was $0.89. The estimated EPS forecast for the
next fiscal year is $7.15 and is expected to report on February
13th, 2020.
To read the full Watsco, Inc. (WSO) report, download it here:
http://Capital-Review.com/register/?so=WSO
-----------------------------------------
COLLEGIUM PHARMACEUTICAL, INC. (COLL) REPORT
OVERVIEW
Collegium Pharmaceutical's Recent Financial
Performance
For the three months ended December 31st, 2018
vs December 31st, 2017, Collegium Pharmaceutical reported revenue
of $73.43MM vs $10.79MM (up 580.26%) and analysts estimated basic
earnings per share $0.28 vs -$0.51. For the twelve months ended
December 31st, 2018 vs December 31st, 2017, Collegium
Pharmaceutical reported revenue of $280.41MM vs $28.48MM (up
884.73%) and analysts estimated basic earnings per share -$1.19 vs
-$2.47. Analysts expect earnings to be released on May 8th, 2019.
The report will be for the fiscal period ending March 31st, 2019.
The reported EPS for the same quarter last year was -$0.57. The
estimated EPS forecast for the next fiscal year is $0.74 and is
expected to report on February 26th, 2020.
To read the full Collegium Pharmaceutical, Inc. (COLL) report,
download it here:
http://Capital-Review.com/register/?so=COLL
-----------------------------------------
CROSS COUNTRY HEALTHCARE, INC. (CCRN) REPORT
OVERVIEW
Cross Country Healthcare's Recent Financial
Performance
For the three months ended December 31st, 2018
vs December 31st, 2017, Cross Country Healthcare reported revenue
of $200.91MM vs $219.67MM (down 8.54%) and analysts estimated basic
earnings per share -$0.56 vs $0.80. For the twelve months ended
December 31st, 2018 vs December 31st, 2017, Cross Country
Healthcare reported revenue of $816.48MM vs $865.05MM (down 5.61%)
and analysts estimated basic earnings per share -$0.48 vs $1.07.
Analysts expect earnings to be released on May 1st, 2019. The
report will be for the fiscal period ending March 31st, 2019. The
reported EPS for the same quarter last year was $0.06. The
estimated EPS forecast for the next fiscal year is $0.21 and is
expected to report on February 26th, 2020.
To read the full Cross Country Healthcare, Inc. (CCRN) report,
download it here:
http://Capital-Review.com/register/?so=CCRN
-----------------------------------------
ABOUT CAPITAL REVIEW
Capital Review is a nationally recognized
publisher of financial analysis, research reports, and exclusive
market reporting. Institutional investors, registered brokers,
professional traders, and personal investment advisers rely on
Capital Review to quantify public company valuations, discover
opportunity across asset classes, stay informed about market-moving
events, and read exclusive analysis of important material
developments. With 14 offices worldwide, Capital Review staffs and
manages certified and registered financial professionals, including
Chartered Financial Analyst® (CFA®) designation holders and FINRA®
BrokerCheck® certified individuals with current and valid CRD®
number designations, to enable continuous coverage of topics
relevant to its regular active reader base.
REGISTERED MEMBER STATUS
Capital Review's oversight and audit staff are
registered analysts, brokers, and/or financial advisers
("Registered Members") working within Equity Research, Media, and
Compliance departments. Capital Review's roster includes qualified
CFA® charterholders, licensed securities attorneys, and registered
FINRA® members holding duly issued CRD® numbers. Current licensed
status of several Registered Members at Capital Review have been
independently verified by an outside audit firm, including policy
and audit records duly executed by Registered Members. Complaints,
concerns, questions, or inquiries regarding this release should be
directed to Capital Review's Compliance department by Phone, at +1
(410) 280-7496, or by E-mail at compliance@Capital-Review.com.
LEGAL NOTICES
Information contained herein is not an offer or
solicitation to buy, hold, or sell any security. Capital Review,
Capital Review members, and/or Capital Review affiliates are not
responsible for any gains or losses that result from the opinions
expressed. Capital Review makes no representations as to the
completeness, accuracy, or timeliness of the material provided and
all materials are subject to change without notice. Capital Review
has not been compensated for the publication of this press release
by any of the above mentioned companies. Capital Review is not a
financial advisory firm, investment adviser, or broker-dealer, and
does not undertake any activities that would require such
registration. For our full disclaimer, disclosure, and terms of
service please visit our website.
Media Contact: Morena Zambada, Media Department
Office: +1 (410) 280-7496 E-mail: media@Capital-Review.com
© 2019 Capital Review. All Rights Reserved. For
republishing permissions, please contact a partner network manager
at partnership@Capital-Review.com.
CFA® and Chartered Financial Analyst® are registered
trademarks owned by CFA Institute.
FINRA®, BrokerCheck®, and CRD® are registered trademarks
owned by Financial Industry Regulatory Authority, Inc.
Pareteum (NASDAQ:TEUM)
Historical Stock Chart
From Aug 2024 to Sep 2024
Pareteum (NASDAQ:TEUM)
Historical Stock Chart
From Sep 2023 to Sep 2024